A recent study showed that O-GlcNAc glycosylation increased the stability of ChREBP, promoted the expression of regulated lipogenic target genes, and aggravated hepatic steatosis in a MASLD mouse model (82). The gene discussed is MLXIPL; the disease is fatty liver disease.